PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498797
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498797
Craniomaxillofacial Devices Market size was valued at USD 1,925.2 Million in 2023, expanding at a CAGR of 10.60% from 2024 to 2032.
Cranio-Maxillofacial Surgery (CMF) is the treatment of congenital and acquired disorders of the head and face. The surgical repair of CMF abnormalities is among the most difficult. The success of these surgeries is determined not only by the technical components of the operation but also by the development of a clear surgical plan and the devices employed. Craniomaxillofacial surgery is the most common procedure performed on patients who require facial or cranial bone therapy as a result of craniomaxillofacial injuries or other trauma fractures. Vehicle accidents are the most common reason for Craniomaxillofacial surgery.
Craniomaxillofacial Devices Market- Market Dynamics
Increasing Number of Sports and Facial Fractures
The increasing number of traffic accidents caused by urbanization and industrialization, as well as the growing demand for successful reconstructive procedures, are likely to drive up the adoption of Craniomaxillofacial (CMF) equipment. The rising incidence of face fractures, primarily from combat sports (about 80%), has resulted in nose and tooth injuries, which account for the majority of injured structures. Kickboxing was considered to be the most deadly fighting sport due to the highest incidence of MF trauma. In addition, as sports and facial fractures become more common, the demand for craniomaxillofacial devices has grown. These devices are used in the surgical treatment and care of facial fractures, providing stability and support to the bones and tissues involved. They help to properly align and heal the fractures, giving for the best functional and aesthetic outcomes.
Craniomaxillofacial Devices Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.60% over the forecast period (2024-2032)
Based on Product segmentation, The CMF plate and screw fixation category had the highest market share in 2023.
Based on Application segmentation, Neurosurgery and ENT were the fastest-growing segments in the market.
On the basis of region, North America was the leading revenue generator in 2023
The Global Craniomaxillofacial Devices Market is segmented on the basis of Product, Material, Application, and Region.
The market is divided into six categories based on Product: CMF Distraction, Cranial Flap Fixation, Thoracic Fixation, Bone Graft Substitute, Temporomandibular Joint Replacement, along with CMF Plate and Screw Fixation. The CMF plate and screw fixation category had the biggest market share in 2023. This dominance is due to its widespread use in a variety of surgical procedures, including orthognathic surgery, deformity correction, tumor removal, as well as pediatric surgery. In contrast, bone graft substitute is expected to develop the fastest during the anticipated period. BGSs are utilized to restore bone abnormalities and fuse the spine. Limited donor availability has resulted in a scarcity of natural bone grafts, creating a demand for bone transplant alternatives.
The market is divided into three categories based on Application: Orthognathic and Dental Surgery, Neurosurgery & ENT, and Plastic surgery. Neurosurgery and ENT were the fastest expanding because of the rising prevalence of trauma and spinal problems that necessitated Cerebrospinal Fluid (CSF) management throughout surgery. Surgeons perform craniotomies to advance better admission to the brain throughout neurosurgery. Craniotomies are performed to treat trauma, brain infections, skull fractures, aneurysms, epilepsy, Parkinson's disease, and pressure in the brain following a stroke or injury and to remove blood clots from a head injury.
Craniomaxillofacial Devices Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America dominated the market in 2023, owing to the availability of technologically improved implants and the growing volume of Craniomaxillofacial (CMF) treatments. Furthermore, factors such as increased awareness of deformity repair surgeries and the presence of established healthcare facilities helped to drive the spectacular rise.
Asia Pacific is expected to have the fastest growth during the projection period. Unexplored potential, constantly increasing healthcare infrastructure, economic development, and expanding patient awareness are the primary impact factors accounting for the lucrative expansion of the craniomaxillofacial business in Asia Pacific.
The global Craniomaxillofacial Devices market is extremely competitive, with several key competitors such as Stryker, Medtronic, DePuy Synthes (J&J), along with B. Braun Melsungen AG, among others. The market is naturally competitive as firms develop new items to obtain market share. To broaden their product offerings, firms are developing research alliances and collaborations with other industry competitors. Companies utilize several software and virtual three-dimensional (3D) technologies to gain a competitive advantage. For instance, the introduction of advanced 3D printing, which allows companies to include components from facial and cranial reconstruction, is anticipated to advance acceptance in the forecast years.
In November 2021, DePuy Synthes introduced the UNIUM System, a next-generation power tool scheme for trauma and minor bone treatments. This method can also be applied to sports medicine, spine, and thoracic procedures.
GLOBAL CRANIOMAXILLOFACIAL DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
DePuy Synthes (J&J),
Stryker
Medtronic
B. Braun Melsungen AG
Reni Shaw plc.
Medartis AG
KLS Martin Group
Xilloc Medical B. V
Synimed
Zimmer-Biomet
Others